Search

everythinglearnresearchcommunity

for

Search:↓

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Minoxidil, tretinoin, and finasteride may help hair regrowth in mild to moderate androgenetic alopecia.

A group has developed therapies that show promise for treating cancer and various other conditions.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

New method uses hair follicle cells to estimate human body clock phase, potentially improving sleep disorder diagnosis.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.